Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1059446

Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy


Arnold, Christopher J.; Johnson, Melissa; Bayer, Arnold S.; Bradley, Suzanne; Giannitsioti, Efthymia; Miró, José M.; Tornos, Pilar; Tattevin, Pierre; Strahilevitz, Jacob; Spelman, Denis et al.
Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy // Antimicrobial Agents and Chemotherapy, 59 (2015), 4; 2365-2373 doi:10.1128/aac.04867-14 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1059446 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy

Autori
Arnold, Christopher J. ; Johnson, Melissa ; Bayer, Arnold S. ; Bradley, Suzanne ; Giannitsioti, Efthymia ; Miró, José M. ; Tornos, Pilar ; Tattevin, Pierre ; Strahilevitz, Jacob ; Spelman, Denis ; Athan, Eugene ; Nacinovich, Francisco ; Fortes, Claudio Q. ; Lamas, Cristiane ; Barsic, Bruno ; Fernández-Hidalgo, Nuria ; Muñoz, Patricia ; Chu, Vivian H.

Izvornik
Antimicrobial Agents and Chemotherapy (0066-4804) 59 (2015), 4; 2365-2373

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
infection, mortality, prognosis, surgery, valves

Sažetak
Background Host factors and complications have been associated with higher mortality in infective endocarditis (IE). We sought to develop and validate a model of clinical characteristics to predict 6‐month mortality in IE. Methods and Results Using a large multinational prospective registry of definite IE (International Collaboration on Endocarditis [ICE]–Prospective Cohort Study [PCS], 2000– 2006, n=4049), a model to predict 6‐month survival was developed by Cox proportional hazards modeling with inverse probability weighting for surgery treatment and was internally validated by the bootstrapping method. This model was externally validated in an independent prospective registry (ICE‐PLUS, 2008–2012, n=1197). The 6‐month mortality was 971 of 4049 (24.0%) in the ICE‐PCS cohort and 342 of 1197 (28.6%) in the ICE‐PLUS cohort. Surgery during the index hospitalization was performed in 48.1% and 54.0% of the cohorts, respectively. In the derivation model, variables related to host factors (age, dialysis), IE characteristics (prosthetic or nosocomial IE, causative organism, left‐sided valve vegetation), and IE complications (severe heart failure, stroke, paravalvular complication, and persistent bacteremia) were independently associated with 6‐month mortality, and surgery was associated with a lower risk of mortality (Harrell's C statistic 0.715). In the validation model, these variables had similar hazard ratios (Harrell's C statistic 0.682), with a similar, independent benefit of surgery (hazard ratio 0.74, 95% CI 0.62–0.89). A simplified risk model was developed by weight adjustment of these variables. Conclusions Six‐month mortality after IE is ≈25% and is predicted by host factors, IE characteristics, and IE complications. Surgery during the index hospitalization is associated with lower mortality but is performed less frequently in the highest risk patients. A simplified risk model may be used to identify specific risk subgroups in IE.

Izvorni jezik
Engleski



POVEZANOST RADA


Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Arnold, Christopher J.; Johnson, Melissa; Bayer, Arnold S.; Bradley, Suzanne; Giannitsioti, Efthymia; Miró, José M.; Tornos, Pilar; Tattevin, Pierre; Strahilevitz, Jacob; Spelman, Denis et al.
Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy // Antimicrobial Agents and Chemotherapy, 59 (2015), 4; 2365-2373 doi:10.1128/aac.04867-14 (međunarodna recenzija, članak, znanstveni)
Arnold, C., Johnson, M., Bayer, A., Bradley, S., Giannitsioti, E., Miró, J., Tornos, P., Tattevin, P., Strahilevitz, J. & Spelman, D. (2015) Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy. Antimicrobial Agents and Chemotherapy, 59 (4), 2365-2373 doi:10.1128/aac.04867-14.
@article{article, author = {Arnold, Christopher J. and Johnson, Melissa and Bayer, Arnold S. and Bradley, Suzanne and Giannitsioti, Efthymia and Mir\'{o}, Jos\'{e} M. and Tornos, Pilar and Tattevin, Pierre and Strahilevitz, Jacob and Spelman, Denis and Athan, Eugene and Nacinovich, Francisco and Fortes, Claudio Q. and Lamas, Cristiane and Barsic, Bruno and Fern\'{a}ndez-Hidalgo, Nuria and Mu\~{n}oz, Patricia and Chu, Vivian H.}, year = {2015}, pages = {2365-2373}, DOI = {10.1128/aac.04867-14}, keywords = {infection, mortality, prognosis, surgery, valves}, journal = {Antimicrobial Agents and Chemotherapy}, doi = {10.1128/aac.04867-14}, volume = {59}, number = {4}, issn = {0066-4804}, title = {Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy}, keyword = {infection, mortality, prognosis, surgery, valves} }
@article{article, author = {Arnold, Christopher J. and Johnson, Melissa and Bayer, Arnold S. and Bradley, Suzanne and Giannitsioti, Efthymia and Mir\'{o}, Jos\'{e} M. and Tornos, Pilar and Tattevin, Pierre and Strahilevitz, Jacob and Spelman, Denis and Athan, Eugene and Nacinovich, Francisco and Fortes, Claudio Q. and Lamas, Cristiane and Barsic, Bruno and Fern\'{a}ndez-Hidalgo, Nuria and Mu\~{n}oz, Patricia and Chu, Vivian H.}, year = {2015}, pages = {2365-2373}, DOI = {10.1128/aac.04867-14}, keywords = {infection, mortality, prognosis, surgery, valves}, journal = {Antimicrobial Agents and Chemotherapy}, doi = {10.1128/aac.04867-14}, volume = {59}, number = {4}, issn = {0066-4804}, title = {Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy}, keyword = {infection, mortality, prognosis, surgery, valves} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font